Literature DB >> 25517135

Why are benzodiazepines not yet controlled substances?

Nicholas Moore1, Antoine Pariente1, Bernard Bégaud1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25517135     DOI： 10.1001/jamapsychiatry.2014.2190

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  15 in total

1.  Continuing Versus New Prescriptions for Sedative-Hypnotic Medications: United States, 2005-2012.

Authors:  Christopher N Kaufmann; Adam P Spira; Colin A Depp; Ramin Mojtabai
Journal:  Am J Public Health       Date:  2016-09-15       Impact factor: 9.308

2.  Need for a realistic appraisal of benzodiazepines.

Authors:  Richard Balon; Giovanni A Fava; Karl Rickels
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

3.  Hypnotics and the Risks of Dementia.

Authors:  Walter James
Journal:  J Clin Sleep Med       Date:  2017-06-15       Impact factor: 4.062

4.  Effectiveness of Benzodiazepine Receptor Agonists in the Treatment of Insomnia: An Examination of Response and Remission Rates.

Authors:  Vivek Pillai; Thomas Roth; Timothy Roehrs; Kenneth Moss; Edward L Peterson; Christopher L Drake
Journal:  Sleep       Date:  2017-02-01       Impact factor: 5.849

Review 5.  Anxiety in Patients Treated with Hemodialysis.

Authors:  Scott D Cohen; Daniel Cukor; Paul L Kimmel
Journal:  Clin J Am Soc Nephrol       Date:  2016-09-22       Impact factor: 8.237

6.  Clinically important drug-drug interactions in poly-treated elderly outpatients: a campaign to improve appropriateness in general practice.

Authors:  Emanuel Raschi; Carlo Piccinni; Vincenzo Signoretta; Lucio Lionello; Silvia Bonezzi; Marcello Delfino; Lucia Di Candia; Lucio Di Castri; Fabio Pieraccini; Daniela Carati; Elisabetta Poluzzi; Fabrizio De Ponti
Journal:  Br J Clin Pharmacol       Date:  2015-11-12       Impact factor: 4.335

7.  Association between anxious symptoms and sleeping medication use among US older adults.

Authors:  Daniel Harris; Lynn McNicoll; Gary Epstein-Lubow; Kali S Thomas
Journal:  Int J Geriatr Psychiatry       Date:  2017-09-29       Impact factor: 3.485

8.  Refining the Definition of Polypharmacy and Its Link to Disability in Older Adults: Conceptualizing Necessary Polypharmacy, Unnecessary Polypharmacy, and Polypharmacy of Unclear Benefit.

Authors:  Eric A Lee; Jeffrey W Brettler; Michael H Kanter; Steven G Steinberg; Peter Khang; Christopher C Distasio; John Martin; Mark Dreskin; Nolan H Thompson; Timothy M Cotter; Kim Thai; Lyn Yasumura; Nancy E Gibbs
Journal:  Perm J       Date:  2019-12-11

Review 9.  A Systematic Review of the Effectiveness of Antianxiety and Antidepressive Agents for Functional Dyspepsia.

Authors:  Mariko Hojo; Akihito Nagahara; Daisuke Asaoka; Yuji Shimada; Hitoshi Sasaki; Kohei Matsumoto; Tsutomu Takeda; Hiroya Ueyama; Kenshi Matsumoto; Sumio Watanabe
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

10.  Patterns in Outpatient Benzodiazepine Prescribing in the United States.

Authors:  Sumit D Agarwal; Bruce E Landon
Journal:  JAMA Netw Open       Date:  2019-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.